Interleukin-10 inhibits osteoclastogenesis by reducing NFATc1 expression and preventing its translocation to the nucleus.
about
Osteoimmunology: interactions of the bone and immune systemThe Alternative Faces of Macrophage Generate OsteoclastsThe Modulatory Effects of Mesenchymal Stem Cells on OsteoclastogenesisOsteoimmunology and the influence of pro-inflammatory cytokines on osteoclastsConditional transgenic expression of PIM1 kinase in prostate induces inflammation-dependent neoplasiaHuman umbilical cord blood-derived CD34+ cells reverse osteoporosis in NOD/SCID mice by altering osteoblastic and osteoclastic activitiesAzilsartan increases levels of IL-10, down-regulates MMP-2, MMP-9, RANKL/RANK, Cathepsin K and up-regulates OPG in an experimental periodontitis model.Estrogen enhances the functions of CD4(+)CD25(+)Foxp3(+) regulatory T cells that suppress osteoclast differentiation and bone resorption in vitro.Endogenous n-3 fatty acids protect ovariectomy induced bone loss by attenuating osteoclastogenesisThe signaling suppressor CIS controls proallergic T cell development and allergic airway inflammation.The E3 ubiquitin ligase GRAIL regulates T cell tolerance and regulatory T cell function by mediating T cell receptor-CD3 degradation.TRPV-5 mediates a receptor activator of NF-kappaB (RANK) ligand-induced increase in cytosolic Ca2+ in human osteoclasts and down-regulates bone resorption.Requirement for the basic helix-loop-helix transcription factor Dec2 in initial TH2 lineage commitment.Negative regulation of osteoclastogenesis and bone resorption by cytokines and transcriptional repressors.Lactobacillus reuteri 6475 Increases Bone Density in Intact Females Only under an Inflammatory SettingAdenosine A2A receptor activation prevents wear particle-induced osteolysisSystemic Administration of Allogeneic Mesenchymal Stem Cells Does Not Halt Osteoporotic Bone Loss in Ovariectomized Rats.Transplanted Human Bone Marrow Mesenchymal Stem Cells Seeded onto Peptide Hydrogel Decrease Alveolar Bone Loss.TLR2 deletion promotes arthritis through reduction of IL-10Lymphocyte-derived cytokines in inflammatory arthritis.Osteoimmunology: cytokines and the skeletal system.The Effect of Long-Term Exercise on the Production of Osteoclastogenic and Antiosteoclastogenic Cytokines by Peripheral Blood Mononuclear Cells and on Serum Markers of Bone Metabolism.Immune regulation of bone loss by Th17 cells.IL-10 suppresses calcium-mediated costimulation of receptor activator NF-kappa B signaling during human osteoclast differentiation by inhibiting TREM-2 expression.Inhibition of RANK expression and osteoclastogenesis by TLRs and IFN-gamma in human osteoclast precursorsOX40L blockade is therapeutic in arthritis, despite promoting osteoclastogenesis.MKP-1 signaling events are required for early osteoclastogenesis in lineage defined progenitor populations by disrupting RANKL-induced NFATc1 nuclear translocation.Interleukin-10 inhibits bone resorption: a potential therapeutic strategy in periodontitis and other bone loss diseases.Conjugated linoleic Acid prevents ovariectomy-induced bone loss in mice by modulating both osteoclastogenesis and osteoblastogenesis.The cardinal role of the phospholipase A(2)/cyclooxygenase-2/prostaglandin E synthase/prostaglandin E(2) (PCPP) axis in inflammostasis.The PIM family of serine/threonine kinases in cancer.A clinical and pathomechanistic profile of chronic nonbacterial osteomyelitis/chronic recurrent multifocal osteomyelitis and challenges facing the field.Role of periodontal ligament fibroblasts in osteoclastogenesis: a review.Osteoimmunology: memorandum for rheumatologists.A review on interleukins: The key manipulators in rheumatoid arthritis.Mechanically loaded myotubes affect osteoclast formation.Inflammatory Bowel Disease in a Rodent Model Alters Osteocyte Protein Levels Controlling Bone Turnover.A benzamide-linked small molecule NDMC101 inhibits NFATc1 and NF-κB activity: a potential osteoclastogenesis inhibitor for experimental arthritis.Phytoestrogens directly inhibit TNF-α-induced bone resorption in RAW264.7 cells by suppressing c-fos-induced NFATc1 expression.Serum calcium-decreasing factor, caldecrin, inhibits osteoclast differentiation by suppression of NFATc1 activity.
P2860
Q24655113-C3F4340F-7965-463A-A465-6DD9E21A02B9Q26765491-75582A2B-3E2F-4D33-B46A-2F27D405DDE0Q26773017-44481971-2E67-473E-AEDB-3179845A441FQ26828486-824A40A6-7102-4EB2-B5FF-50F440AF9B0FQ28485913-78976633-AF54-4243-8176-147FDD73EA1DQ28728315-EF42646E-F42D-463A-B728-0E2EDF2F6173Q31161038-AE0C5C96-B2C3-4846-9610-2F4B932E54AEQ33784120-F8E1E746-F9AD-4259-B2BE-13D130FA76C6Q33793981-D4F9C9B3-4FC7-46C4-8AAA-ADE649718CADQ33855162-7C907398-7CBA-4969-92C4-5B17870C267DQ34041946-F06E5024-4018-4524-A1E4-021945BD9959Q34055772-682BA05C-8783-4152-910C-E3E0D73AA57FQ35010851-F24C309C-D1CE-4FF0-A290-D048BDB8B71EQ35617591-84E1E937-5345-4046-B97D-C9F96836B07BQ35983499-D35A089C-245D-410B-9552-AB7ED5CBB69CQ36067491-9BFCF871-572B-4D7E-82C7-AEFE416FF3B5Q36155376-A6CE1285-E1F7-4154-80AA-4E60C8F0E645Q36574491-3B1CDC9C-9FB3-45B0-81F2-47299E8119A0Q36775416-019731D3-6B32-4A2A-AF59-16D40C5D8C13Q37118786-A3E1A073-6944-4553-B378-CFEC54FB5B5FQ37235713-B816C502-C574-48AD-882D-9D48FC60F636Q37236070-6AAFA882-1A1A-4E9F-A136-CB3B71C19CFDQ37317215-80AD9332-443C-4AB6-8258-0C528E1BA8B5Q37342418-034F999E-0392-4BA0-9171-B4CCD003C842Q37438518-3DAF1B90-D273-4A88-830D-A13C0CAA744EQ37587734-078234B9-931A-4361-B892-963C3D587867Q37622034-8336C7DE-9489-47AF-AEB6-03FE8952CD05Q37626939-0B3D0DCA-ACA5-4BC3-A42F-F399C24D74BFQ37627024-0EE4E4E3-FA8D-4556-9806-ED7D27296AD1Q37941508-2491D77D-A26F-473E-B93C-A0B02D5BA9C9Q38098139-0E740E00-C6A0-480B-84F8-6DDBFCD540D3Q38144108-199925B5-043B-45B5-A6F1-91B5C9410C92Q38215027-F73B6D62-756D-47E8-9FCF-D706FCF5654AQ38960189-8BA0047B-C42F-4FB1-9EA3-172C245F8A69Q39029629-E3012BED-8E5B-4976-8BC5-71660F3F6E8FQ39058675-DB104728-8489-4038-B9B9-63A24AA41C57Q39234455-79EC72AA-B0FD-4091-AE11-4B7C17AF1A5EQ39384250-B7A63664-03C9-4B80-9B26-2F27F4447BDCQ39602490-3206CADD-5A41-4DB5-A838-5351356E0860Q39693083-3D841BDF-A16C-414B-8AB1-83761FB10327
P2860
Interleukin-10 inhibits osteoclastogenesis by reducing NFATc1 expression and preventing its translocation to the nucleus.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Interleukin-10 inhibits osteoc ...... translocation to the nucleus.
@ast
Interleukin-10 inhibits osteoc ...... translocation to the nucleus.
@en
type
label
Interleukin-10 inhibits osteoc ...... translocation to the nucleus.
@ast
Interleukin-10 inhibits osteoc ...... translocation to the nucleus.
@en
prefLabel
Interleukin-10 inhibits osteoc ...... translocation to the nucleus.
@ast
Interleukin-10 inhibits osteoc ...... translocation to the nucleus.
@en
P2860
P356
P1433
P1476
Interleukin-10 inhibits osteoc ...... translocation to the nucleus.
@en
P2093
Kathryn E Evans
P2860
P2888
P356
10.1186/1471-2121-8-4
P50
P577
2007-01-19T00:00:00Z
P5875
P6179
1022998391